Non-alcoholic Fatty Liver Disease and Its Links with Inflammation and Atherosclerosis Luan Rodrigues AbdallahRicardo Cardoso de MatosPriscila Pollo-Flores Evidence-Based Medicine, Clinical Trials and Their Interpretations (L. Roever, Section Editor) 04 February 2020 Article: 7
Correction to: Atherothrombosis Prevention and Treatment with Anti-interleukin-1 Agents Giuseppe Biondi-ZoccaiCristian M. GarmendiaFrancesco Versaci Correction 29 January 2020 Article: 6
Pemafibrate, a New Selective PPARĪ± Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases Shizuya YamashitaDaisaku MasudaYuji Matsuzawa Nonstatin Drugs (R. Carmena, Section Editor) Open access 23 January 2020 Article: 5
Atherothrombosis Prevention and Treatment with Anti-interleukin-1 Agents Giuseppe Biondi-ZoccaiCristian M. GarmendiaFrancesco Versaci Evidence-Based Medicine, Clinical Trials and Their Interpretations (L. Roever, Section Editor) 13 January 2020 Article: 4
Cardiovascular Disease Prevention in Focus: Highlights from the 2019 American Heart Association Scientific Sessions Anurag MehtaDhruv MahttaSalim S. Virani Reviews and New Research Implications (S. Virani, Section Editor) 11 January 2020 Article: 3